A rare case of a gabapentin-induced cardiomyopathy.
adverse effect
cardiomyopathy
cardiovascular disease
Journal
Journal of clinical pharmacy and therapeutics
ISSN: 1365-2710
Titre abrégé: J Clin Pharm Ther
Pays: England
ID NLM: 8704308
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
23
01
2019
revised:
14
03
2019
accepted:
17
03
2019
pubmed:
11
4
2019
medline:
20
12
2019
entrez:
11
4
2019
Statut:
ppublish
Résumé
Gabapentin, a γ-aminobutyric acid derivative, is used for the treatment of partial onset seizures, postherpetic neuralgia, diabetic neuropathy and a host of other neurological disorders. A 44-year-old woman with spinal stenosis was prescribed gabapentin for pain. Two months after initiating therapy, she was diagnosed with a new-onset non-ischaemic cardiomyopathy with an ejection fraction of 36% measured on a transthoracic echocardiogram. A patient with suspected gabapentin-induced cardiomyopathy is reported. However, to date, gabapentin therapy has not been associated with risk of the developing a cardiomyopathy.
Substances chimiques
gamma-Aminobutyric Acid
56-12-2
Gabapentin
6CW7F3G59X
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
644-646Informations de copyright
© 2019 John Wiley & Sons Ltd.